Histamine Antagonists

"Histamine Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.

Descriptor ID	D006633
MeSH Number(s)	D27.505.519.625.375.425 D27.505.696.577.375.425
Concept/Terms	Histamine Antagonists Histamine Antagonists Antagonists, Histamine Antihistamines

Below are MeSH descriptors whose meaning is more general than "Histamine Antagonists".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
Histamine Agents [D27.505.519.625.375]
Histamine Antagonists [D27.505.519.625.375.425]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Histamine Agents [D27.505.696.577.375]
Histamine Antagonists [D27.505.696.577.375.425]

Below are MeSH descriptors whose meaning is related to "Histamine Antagonists".

Below are MeSH descriptors whose meaning is more specific than "Histamine Antagonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Histamine Antagonists" by people in this website by year, and whether "Histamine Antagonists" was a major or minor topic of these publications.

Bar chart showing 20 publications over 16 distinct years, with a maximum of 2 publications in 2005 and 2009 and 2019 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2002	1	0	1
2003	1	0	1
2005	2	0	2
2006	1	0	1
2009	0	2	2
2010	1	0	1
2011	1	0	1
2012	1	0	1
2013	1	0	1
2014	0	1	1
2015	0	1	1
2019	2	0	2
2020	1	0	1
2021	1	0	1
2024	0	2	2

Below are the most recent publications written about "Histamine Antagonists" by people in Profiles.

Rayner DG, Liu M, Chu AWL, Chu X, Guyatt GH, Oykhman P, Cao DJ, Moellman J, Ben-Shoshan M, Baker DR, Waserman S, Lang D, Sheikh J, Mathur SK, Beck LA, Khan DA, Oliver ET, Asiniwasis RN, Cole EF, Wheeler KE, Runyon L, Chan J, Trayes KP, Eftekhari S, Gardner DD, Winders T, Saini SS, Bernstein JA, Chu DK. Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials. J Allergy Clin Immunol. 2024 Oct; 154(4):996-1007.

View in: PubMed
Chu X, Wang J, Ologundudu L, Brignardello-Petersen R, Guyatt GH, Oykhman P, Bernstein JA, Saini SS, Beck LA, Waserman S, Moellman J, Khan DA, Ben-Shoshan M, Baker DR, Oliver ET, Sheikh J, Lang D, Mathur SK, Winders T, Eftekhari S, Gardner DD, Runyon L, Asiniwasis RN, Cole EF, Chan J, Wheeler KE, Trayes KP, Tran P, Chu DK. Efficacy and Safety of Systemic Corticosteroids for Urticaria: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Allergy Clin Immunol Pract. 2024 Jul; 12(7):1879-1889.e8.

View in: PubMed
Janeczko P, Norris MR, Bielory L. Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease. Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):480-485.

View in: PubMed
Kimchi N, Bielory L. The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents. Curr Opin Allergy Clin Immunol. 2020 08; 20(4):414-420.

View in: PubMed
Bielory L, Schoenberg D. Emerging Therapeutics for Ocular Surface Disease. Curr Allergy Asthma Rep. 2019 02 28; 19(3):16.

View in: PubMed
Vishnevsky A, Savage MP, Fischman DL. Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach. Curr Vasc Pharmacol. 2019; 17(2):123-126.

View in: PubMed
Steinweg SA, Gaspari AA. Rituximab for the Treatment of Recalcitrant Chronic Autoimmune Urticaria. J Drugs Dermatol. 2015 Dec; 14(12):1387.

View in: PubMed
Bielory L. A 37-year-old man referred for assistance with persistent asthma, atopic dermatitis, and chronic conjunctivitis. Ann Allergy Asthma Immunol. 2014 Apr; 112(4):290-5.

View in: PubMed
Bielory L, Meltzer EO, Nichols KK, Melton R, Thomas RK, Bartlett JD. An algorithm for the management of allergic conjunctivitis. Allergy Asthma Proc. 2013 Sep-Oct; 34(5):408-20.

View in: PubMed
Wade L, Bielory L, Rudner S. Ophthalmic antihistamines and H1-H4 receptors. Curr Opin Allergy Clin Immunol. 2012 Oct; 12(5):510-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement